Importantly, treatment with WJA88 resulted in a significant decrease in proliferative tumour cells (Ki67+/tdTomato+, WJA88 = 10.6% vs Vehicle = 15.4%; Fig. 8d–f), confirming anti-proliferative efficacy of WJA88 in vivo. Here, MKI67 is linked to neoplasm.